文献速递结核与非结核分枝杆菌艾滋病与性传播感染

HIV合并感染者结核治疗期间宿主基因表达动力学不依赖高效抗逆转录病毒治疗

Host Gene Expression Kinetics During Treatment of Tuberculosis in HIV-Coinfected Individuals Is Independent of Highly Active Antiretroviral Therapy.
PubMed 文献 · J Infect Dis · 2018-01-01

研究在埃塞俄比亚亚的斯亚贝巴纳入131例HIV感染者,其中活动性结核48例、潜伏性结核感染37例、无结核感染对照46例,用双色逆转录多重连接依赖探针扩增法检测105个免疫相关基因表达。结果发现7个基因的基线表达谱可准确区分活动性结核与潜伏性及无结核感染,且基本不依赖高效抗逆转录病毒治疗(HAART)资格;抗结核治疗6个月后结核患者生物标志物谱与潜伏性结核感染患者及对照无法区分,宿主基因表达动力学不依赖HAART使用。

要点

  • 7个基因基线表达谱可区分HIV合并感染者中的活动性结核与潜伏性及无结核感染
  • 抗结核治疗6个月后结核患者基因表达谱与潜伏性结核感染患者及对照无法区分
  • 宿主基因表达动力学在抗结核治疗期间不依赖HAART使用

核心结论

  • 血液转录组谱可能可作为生物标志物,用于区分HIV合并感染者结核的不同临床阶段,并监测接受HAART者和未治疗者的结核治疗反应。

研究设计与样本

  • 在埃塞俄比亚亚的斯亚贝巴,采用双色逆转录多重连接依赖探针扩增法检测131例HIV感染者105个免疫相关基因的表达水平,其中活动性结核48例、潜伏性结核感染37例、无结核感染对照46例。

主要发现

  • 在HIV阳性受试者队列中,基线时7个基因(FCGR1A、RAB24、TLR1、TLR4、MMP9、NLRC4和IL1B)的表达谱可准确区分活动性结核与潜伏性及无结核感染,且基本不依赖HAART资格。
  • 抗结核治疗6个月后,结核患者的生物标志物谱与潜伏性结核感染患者及对照无法区分。
  • HIV合并感染者抗结核治疗期间的宿主基因表达动力学不依赖HAART使用。

临床怎么用

  • 作者认为血液转录组谱可能可作为生物标志物,用于区分HIV合并感染者结核的不同临床阶段,并监测接受HAART者和未治疗者的结核治疗反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limitations in diagnostic tools to discriminate between active tuberculosis and latent Mycobacterium tuberculosis infection and for monitoring antituberculosis treatment responses are major challenges in tuberculosis control, especially in human immunodeficiency virus (HIV)-coinfected individuals. METHODS: Expression levels of 105 immune-related genes were determined in 131 HIV-infected patients with active tuberculosis (n = 48), patients with latent M. tuberculosis infection (LTBI; n = 37), and controls with no M. tuberculosis infection (n = 46) in Addis Ababa, Ethiopia, using focused gene expression profiling with a dual-color reverse-transcription multiplex ligation-dependent probe amplification assay. RESULTS: Within the cohort of HIV-positive subjects, the expression profiles of 7 genes at baseline (FCGR1A, RAB24, TLR1, TLR4, MMP9, NLRC4, and IL1B) could accurately discriminate between active tuberculosis and both latent and no M. tuberculosis infection, largely independently of (in)eligibility for highly active antiretroviral therapy (HAART). Six months after antituberculosis treatment, biomarker profiles of patients with tuberculosis became indistinguishable from those of patients with LTBI and controls. Importantly, host gene expression kinetics during antituberculosis treatment in HIV-coinfected individuals was found to be independent of HAART use. CONCLUSIONS: Blood transcriptomic profiles can potentially be used as biomarkers to discriminate the different clinical stages of tuberculosis in HIV-coinfected individuals and to monitor tuberculosis treatment responses in both HAART recipients and untreated individuals.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gebremicael G, Kassa D, Quinten E, et al. Host Gene Expression Kinetics During Treatment of Tuberculosis in HIV-Coinfected Individuals Is Independent of Highly Active Antiretroviral Therapy. J Infect Dis. 2018. PMID: 29982697. doi:10.1093/infdis/jiy404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。